180 related articles for article (PubMed ID: 29795309)
1. Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams).
Grønhøj C; Jensen DH; Dehlendorff C; Marklund L; Wagner S; Mehanna H; Munck-Wikland E; Ramqvist T; Näsman A; Wittekindt C; Würdemann N; Sharma SJ; Gattenlöhner S; Kiss K; Andersen E; Spruce R; Batis N; Robinson M; Harrington K; Winter S; Jones TM; Klussmann JP; Dalianis T; Friborg J; von Buchwald C
Br J Cancer; 2018 Jun; 118(12):1672-1681. PubMed ID: 29795309
[TBL] [Abstract][Full Text] [Related]
2. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
[TBL] [Abstract][Full Text] [Related]
3. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
4. Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients.
Larsen CG; Jensen DH; Carlander AF; Kiss K; Andersen L; Olsen CH; Andersen E; Garnæs E; Cilius F; Specht L; von Buchwald C
Oncotarget; 2016 Nov; 7(44):71761-71772. PubMed ID: 27708214
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
[TBL] [Abstract][Full Text] [Related]
7. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
[TBL] [Abstract][Full Text] [Related]
8. What is the predictive value of OroGrams to estimate survival rates of HPV-positive oropharyngeal squamous cell carcinoma?
Robbins J; Ali K
Evid Based Dent; 2022 Mar; 23(1):14-15. PubMed ID: 35338318
[TBL] [Abstract][Full Text] [Related]
9. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
Fakhry C; Zhang Q; Nguyen-Tân PF; Rosenthal DI; Weber RS; Lambert L; Trotti AM; Barrett WL; Thorstad WL; Jones CU; Yom SS; Wong SJ; Ridge JA; Rao SSD; Bonner JA; Vigneault E; Raben D; Kudrimoti MR; Harris J; Le QT; Gillison ML
J Clin Oncol; 2017 Dec; 35(36):4057-4065. PubMed ID: 28777690
[TBL] [Abstract][Full Text] [Related]
11. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
Garset-Zamani M; Carlander AF; Jakobsen KK; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; von Buchwald C
Int J Cancer; 2022 Apr; 150(7):1174-1183. PubMed ID: 34894151
[TBL] [Abstract][Full Text] [Related]
12. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
13. Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma.
Gorphe P; Chekkoury Idrissi Y; Tao Y; Moya-Plana A; Casiraghi O; Janot F; Blanchard P; Mirghani H; Temam S
Head Neck; 2019 Apr; 41(4):1039-1045. PubMed ID: 30552841
[TBL] [Abstract][Full Text] [Related]
14. Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual.
Beltz A; Gösswein D; Zimmer S; Limburg I; Wünsch D; Gribko A; Deichelbohrer M; Hagemann J; Stauber RH; Künzel J
Eur J Surg Oncol; 2019 Jun; 45(6):1046-1053. PubMed ID: 30857877
[TBL] [Abstract][Full Text] [Related]
15. Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.
Ren J; Xu W; Su J; Ren X; Cheng D; Chen Z; Bender N; Mirshams M; Habbous S; de Almeida JR; Perez-Ordonez B; Goldstein DP; Wang JR; Bratman SV; Huang SH; Jang R; Zhao Y; Waterboer T; Hung RJ; Liu G
Int J Cancer; 2020 Apr; 146(8):2166-2174. PubMed ID: 31269236
[TBL] [Abstract][Full Text] [Related]
16. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany.
Reuschenbach M; Tinhofer I; Wittekindt C; Wagner S; Klussmann JP
Cancer Med; 2019 Apr; 8(4):1908-1918. PubMed ID: 30821126
[TBL] [Abstract][Full Text] [Related]
19. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
[TBL] [Abstract][Full Text] [Related]
20. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
